HomeNRXBF • OTCMKTS
add
Nurexone Biologic Inc
Previous close
$0.46
Year range
$0.22 - $0.88
Market cap
48.33M CAD
Avg Volume
11.32K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.28M | 10.40% |
Net income | -1.25M | -7.94% |
Net profit margin | — | — |
Earnings per share | -0.02 | — |
EBITDA | -1.27M | -10.56% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.52M | 120.73% |
Total assets | 3.61M | 156.13% |
Total liabilities | 686.00K | -0.58% |
Total equity | 2.93M | — |
Shares outstanding | 70.89M | — |
Price to book | 11.38 | — |
Return on assets | -93.03% | — |
Return on capital | -115.58% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.25M | -7.94% |
Cash from operations | -818.00K | -3.68% |
Cash from investing | -301.00K | -30,200.00% |
Cash from financing | 1.26M | 19.79% |
Net change in cash | 138.00K | -47.53% |
Free cash flow | -796.38K | -117.29% |
About
Founded
2011
Website
Employees
12
